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1. List of abbreviations 
6MWT    Six meter walk test   
ABG    Arterial Blood gas  
BIS Bispectral index  
CABG     Coronary artery bypass graft 
COPD    Chronic obstructive pulmonary disease 
CPB    Cardio-pulmonary bypass 
CRA    Cardiac recovery area 
CXR    Chest x-ray 
EF    Ejection fraction 
FT    Fast-track 
FTCA    Fast-track cardiac anaesthesia 
FTF    Fast-track failure 
GA    General anaesthesia  
IABP    Intra-aortic balloon pumping 
ICU Intensive care unit 
IMC    Intermediate care unit 
IQR    Interquartile range 
LOS    Length of stay 
LQ    Lower quartile 
LV    Left ventricle 
MAC    Minimum alveolar concentration 
Nu-DESC    Nursing delirium screening scale  
OR    Operation room 
P.S.   Pressure support 
PACU    Post anaesthesia care unit 
PCA    Patient controlled analgesia  
PCSU    Post cardiac surgery unit 
POCD    Postoperative cognitive dysfunction  
PONV Postoperative nausea and vomiting  
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PSV    Pressure support ventilation 
Scvo2    Central venous oxygen Saturation 
SD    Standard deviation 
TEA    Thoracic epidural anaesthesia  
TOF    Train-of-four 
UQ    Upper quartile 
VAS    Visual analogue score 
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3. Abstract: 
A Fast-track pathway has become an integral part of cardiac anaesthesia. It enhances rapid 
extubation and reduces intensive care unit length of stay, without affecting the quality of care[1]. 
The Leipzig Fast-track protocol has been applied since 2005 and uses remifentanil continuous 
infusion as a main opioid for intraoperative maintenance of anaesthesia[2]. Remifentanil was 
unavailable in Germany from February to July 2017, therefore the protocol had to be modified 
and sufentanil was used instead.   
In this study we retrospectively compared patients receiving remifentanil (February to July 2016) 
with patients receiving sufentanil (February to July 2017) undergoing fast-track cardiac surgery to 
evaluate differences between the two opioids concerning ventilation time (i.e. time from arrival 
on the post-anaesthesia care unit until tracheal extubation), length of stay in the post-anaesthesia 
care unit, visual analogue pain scores and piritramide consumption on the day of the operation. 
 
Patients from the two time periods were matched using a propensity score matching resulting in 
609 patients in each group. The remifentanil group had a significantly shorter median (IQR 
[range]) ventilation time compared with the sufentanil group; 70(50-100 [5-315]) vs 110 (80-150 
[15-370]) min, p=<0.001, shorter mean (SD) length of stay in the post-anaesthesia care unit; 263 
(78) vs 277 (77) min, p=0.002 and longer hospital length of stay 15.5(8.8) vs 14.1(6.1), p=0.02. The 
remifentanil group had a higher mean (SD) visual analogue pain score than the sufentanil group; 
2.4 (1.5) vs 1.5 (1.2), p <0.001 and consumed more mean (SD) piritramide; 18.9 (7.3) vs 2.6 (4.7) 
mg, p <0.001. The results of our study show that although remifentanil was more effective in 
reducing time to tracheal extubation and length of stay in the post-anaesthetic care unit, there 
was an increased requirement for piritramide with longer hospital length of stay when 




4.1 Fast track cardiac anaesthesia: 
4.1.1 Definitions: 
Fast track (FT) surgery is a concept described by Kehlet and colleagues[3] for patients undergoing 
colonic surgery. It consists of proper integrated and interdisciplinary perioperative patient’s 
management, which helps the patients’ quick recovery and discharge from the hospital without 
affecting morbidity and mortality. Moreover, it reduces health care costs without increasing social 
burden. Staff training, patient education and procedures plans reorganization are all involved in 
fast-track surgery (Figure 1). 
 
Figure 1: Interventions needed for major improvement in surgical outcome[3]. 
 
On the other hand, post-cardiac surgery care is a multidisciplinary process that uses multimodal 
managements to improve efficiency, patients’ safety and use of resources.  
Combing FT in post-cardiac surgery care resulted in what is called “ Fast track cardiac anaesthesia” 
(FTCA), which was first introduced in the early 1990s[4]. 
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For long time, cardiac surgery patients were given a high-dose opioid anaesthesia regime with 
long acting muscle relaxants to be ventilated overnight following their surgery. FTCA includes 
early extubation (<6hrs) leads to avoidance or short intensive care unit (ICU) stay and 
consequently early hospital discharge[5]. The imbalance between the demands and resources is 
the main motivation for evolution of such technique.   
 
4.1.2 Current evidence of FTCA: 
The mainstay of FTCA studies are; the safety of the technique, its efficiency and the costs benefits. 
The three topics were first discussed by the series of studies by Cheng et al. [6-8].  
 
4.1.2.1 The safety of FTCA: 
The safety of any new technique is usually tested by comparing its morbidity and mortality rate 
with the conventional high dose opioids based management as gold standard. Myles and 
colleagues[9] undergone a systematic review for six trials comparing mortality and morbidity  for 
FTCA versus the conventional management and found no evidence of increase mortality and 
morbidity in FTCA patients. In a Cochrane review, comparing early extubation vs routine care, 
there was no significant difference in common complications such as reintubation rate, stroke 
and myocardial infarction as well as mortality rate during hospital length of stay (LOS), at 1 year 
or at any time during follow up[1]. Two other large studies could not find significant difference 
between both techniques [2, 10]. “Ultra-FT” is the term referred to immediate extubation in the 
operating theater and also found to be safe [11]. 
Moreover, in the same Cochrane review, they also compared FTCA with low dose to regular dose 
narcotic and found no differences in the risk of adverse events or mortality[1]. 
 
4.1.2.2 The efficiency of FTCA:  
The effect of FTCA on reducing ventilation time (time to extubation), ICU- LOS, intermediate care 
(IMC)-LOS and hospital-LOS is well studied. The use of low-dose opioid anaesthesia and/or a time-
directed extubation protocol is associated by reduction in time to extubation and in the ICU-
LOS[1]. These two FT interventions are not associated with reduction of hospital-LOS[1]. This may 
attributed to organizational logistics and regulations that may hinder early hospital discharge for 
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suitable patients. To implement an effective FTCA pathway, the entire process of care must be 
modified, which is sometimes difficult. Modifications may include creation of step-down units 
that is separate from the ICU, modification to nursing coverage in ICU and using of telemetry 
monitoring[12].  
Comparing quality of life is less investigated. Van Mastrigt [13] could show improvement in the 
physical and social functioning in FT patients at 1 month postoperatively. However, it was similar 
in both groups after 1 year. 
 
4.1.2.3 Economic Implications of FTCA: 
Most countries (including Germany) have increased the number of ICU beds to face increased 
demands [14, 15]. In Germany, the total ICU expenses consume about 20% of the overall hospital 
costs [16]. The most costly units after uncomplicated CABG are ICU and OR[7]. Moreover it was 
proved that, the first day of ICU admission has the highest impact on costs[17]. Therefore, FTCA 
have high impact on cost reduction by shortening or avoiding ICU admission[18]. In FTCA, the 
patients are transferred earlier to step-down units with lower nurse to patient ratio, leads to less 
staff expenses. Staffing represents 45-62% of total ICU costs[19]. The rest ICU costs are made up 
by supporting services (22-25%), supplies and equipment (15-20%) and drugs (4-13%)[19]. The 
implementation of specialized postoperative care unit (PACU), rather with limited opening 
hours[20], supports FT protocols implantation[21], increases safety and is cost effective[22].  
 
4.1.3 Different FTCA pathways: 
The primary driver for FTCA is cost reduction, which was difficult to be proved at the beginning of 
FT era. The evidences that FTCA reduces ICU LOS were weak, despite of reduction of 
postoperative ventilation time. This was hypothesized by incomplete switch of the hospital 
system to suit the FT idea[12]. Effective FTCA includes change of the entire process during surgery 
(e.g. maintain patient temperature, maneuvers to decrease postoperative bleeding) and 
postoperative pathways or model of care which has huge impact on cost. 
Cheng et al.[23] had presented different postoperative pathway models for FTCA. 
Postoperatively, FT patients can be transferred either conventionally to common ICU, or to an 
ICU with special FT section (Integrated model) or to a separate postoperative care unit (PACU) 
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(Parallel model) or directly to step down unit if ultra-FT had been used (Figure 2). The flexibility 
in the staffing ratio according to the acuity of illness is the major advantage of these models and 
is the primary source of costs reduction. Probst el al. [21] compared FT in conventional model 
with that in PACU. The FT PACU patients were extubated faster (90 min. vs 478 min) and 
transferred to step down unit earlier (3.3 vs 17.9 hours). 
 
  
Figure 2: modified from [12, 24] Process of care.  
ICU, intensive care unit; CRA, cardiac recovery area; PCSU, post cardiac surgery unit; PACU, post 
anaesthesia care unit 
 
4.1.4 Patient selection and optimization: 
 
Some authors suggested that, every patient could “basically” be suitable for FTCA.[25] However, 
literature showed FT failure (FTF) rates between 15.6% and 45.5%.[26, 27] Avoidance of risk 
factors that may lead to FTF or to prolonged ICU LOS, might be the best FTCA selection 
criteria[28]. Combined preoperative and intraoperative factors were been suggested to prolong 
ICU LOS independently. For example; age, chronic lung disease, high EuroScore [29], renal 
dysfunction, unstable angina, heart failure, re-do or combined surgery, prolonged 
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cardiopulmonary bypass (CPB)[30], transfusion more than four red blood cells (RBC) or 
plasma[31], sex, arrhythmias, mitral insufficiency, aortic surgery and intra-aortic balloon 
pumping(IABP)[32]. Furthermore, risk model were constructed to predict if the patient will have 
a prolonged ICU stay or not[32]. Prolonged ICU stay in cardiac surgery is related to postoperative 
mortality rate [33]. 
On the same way, risk factors and predictors for FTF were intensively examined [10, 26, 28, 34, 
35]. Accordingly, some authors tried to construct a prediction model to predict FTF[26]. More 
recently, an operating room extubation prediction scoring system was validated by Subramaniam 
and coworkers[36]. Different studies have been used to stratify the patients into three groups of 
risk; low risk patients with higher success rate, medium risk and high risk with lower success rate 
(Figure 3)[28].  
 
Figure 3: Recommended selection criteria and patient stratification[28]. 
CPB: Cardiopulmonary Bypass, COPD: Chronic obstructive pulmonary disease, 6MWT: Six meter 
walk test, EF: Ejection fraction. 
 
Unfortunately, most of these factors are not modifiable (e.g. age, sex). However, patient 
optimizing strategies should focus on the modifiable factors. For example, protecting renal 
function can be reached by; keeping the hemodynamics stability, choice of fluids and reduce 
intravenous contrast media exposure short before surgery. Preoperative anemia and respiratory 
function can be modified in the same way. 
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FTF prediction and patient stratification are very useful for OR organization. Scheduling the FT 
patients first could be advantageous in keeping the FT program running well. Good 
communication and close cooperation between all the subjects involved in the patient care (e.g. 
OR manager, anesthesiologist, cardiac surgeon, cardiologist, perfusionist, nurses, 
intensivist…etc.) (heart-team approach) are fundamental for patient selection and optimization 
and finally a successful program. 
 
4.1.5 Anaesthesia aspects of FT: 
The previous standard of care in cardiac anaesthesia was based on high dose opioids (e.g 
morphine, fentanyl) and long-acting agents (e.g. midazolam, pancuronium) with postoperative 
sedation and mechanical ventilation for 6-24 hours. This protocol was largely shifted to short-
acting agents enhancing early extubation. This was initiated by using propofol as a hypnotic agent 
(1-1.5mg/kg) or etomidate (0.2-0.3 mg/kg), reduced fentanyl dose (up to 15µg/kg) or using other 
novel opioids (e.g. remifentanil (0.2-0.5µg/kg/min), sufentanil(0.25-0.5µg/kg)) and short acting 
muscle relaxant as rocuronium 1mg/kg. Maintenance of anaesthesia may be achieved using 
continuous remifentanil/sufentanil infusion plus propofol or sevoflurane[37]. However, for 
successful FTCA, cardiac anesthesiologist has to do more than simple using of short-acting 
anaesthetics allowing early extubation and recovery. For example, depth of anaesthesia 
monitoring using derived cerebral electrical signals (e.g bispectral index (BIS) or Narcotrend) 
supports FT management. It can prevent inadequate anaesthesia in form of light anaesthesia and 
awareness or too deep anaesthesia and possible postoperative delirium especially in elderly 
patients [38, 39]. Good Intraoperative (and postoperative) temperature management is another 
prerequisite for successful FT. This can be achieved by practicing normothermic or mild 
hypothermic (> 32°C) cardiac surgery with standard application of forced-air or circulating-water 
devices and infusion warmer devices. Another challenge facing cardiac anesthesiologist is 
excessive bleeding prevention and management. Preoperative coagulation and antiplatelet 
optimization, intraoperative use of tranexamic acid, meticulous hemostasis and use of point-of-
care (e.g. visco-elastic tests) for early diagnosis and directed-management could reduce 
postoperative bleeding and enhance successful FTCA.  
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Using thoracic epidural anaesthesia (TEA) as a supplementary measure in FT program is still point 
of debate. Its theoretical benefits of reducing intravenous opioids and better pain control with 
better ventilatory function[40] must be weighed against the possible epidural hematoma 
formation under systemic anticoagulation.  
 
4.1.6 Cardiopulmonary bypass aspects of FT: 
Many early postoperative complications (e.g. bleeding, respiratory and neurological 
complications), which hindered FT process, can occur during CBP period. In general, avoidance of 
CPB (e.g. off-pump coronary bypass or transcatheter valve implantation) is preferable. If CPB is a 
must, short CPB is preferable. Some measures must be taken to reduce complications rate. Severe 
hemodilution (hematocrit <24%) may lead to acute kidney injury[41]. It can be prevented by 
minimizing priming volume, ultrafiltration and vacuum-assisted venous return. Biocompatible 
CPB circuit and oxygenator are associated with shorter ICU LOS[42]. The use of “minimally 
invasive CPB” using close circuits with separation of shed blood from the surgical field, with or 
without the application of a reduced systemic anticoagulation [43], was shown to reduce 
postoperative complication [44]. 
 
4.2 Leipzig FT Protocol: 
Leipzig FT protocol was first introduced in November 2005 for elective cardiac surgery patients in 
the heart center of Leipzig University. The primary main changes were switching of the opioid 
regime to remifentanil and the postoperative management in a specialized PACU, bypassing ICU 
admission [2, 22]. PACU consisted of 3 beds (upgraded to 8 beds on 2012) operated exclusively 
by anesthesiologists and anaesthesia nursing staff with a nurse to patient ratio of 1:3 and 
physician to patient ratio of 1:4. The PACU was operated daily Monday to Friday from 10:00am 
to 6:30pm. As of 2012 it is operated from 10:00am to 10:30pm. A 24hour operating time model 
was tested during the transitional period and was compared with 12hour model and found to be 
less effective[20]. 
Patients included in this protocol were preselected according to the preoperative medical 
condition and the planned surgery. Clinical judgment and communication between 
anesthesiologists and the surgeons at the end of the operation is mandatory. All patients were 
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admitted to the PACU (i.e. inclusion criteria) if they were hemodynamically stable, without or with 
minimal inotropic support, without excessive bleeding, and with a core temperature of at least 
36°C. Only patients scheduled for elective cardiac surgery were admitted to the PACU. Elective 
surgeries include both elective and urgent (surgery performed on next working day) operations. 
Emergency surgeries (surgery performed immediately) were excluded. (Table 1) 
Table 1: Inclusion Criteria for Fast Tracking 
 Hemodynamically stable  
 ± Low-dose inotropic support (continuous infusion of < 0.1µg/kg/min of 
norepinephrine and/or < 0.05 µg/kg/min of epinephrine or <5 µg/kg/min)  
 No excessive bleeding  
 Core temperature ≥36⁰C  
 Elective or urgent surgeries (not emergency surgeries)  
 
Leipzig fast-track protocol consists of oral premedication with dipotassium clorazepate the 
evening before and midazolam on the day of surgery. Recently, preoperative oral premedication 
is omitted to reduce postoperative delirium rate[45] and to enhance fast extubation, except in 
rare cases. Anaesthetic induction is performed with propofol (1–2 mg/ kg), fentanyl (200µg), and 
rocuronium (0.6 mg / kg) or Atracurium (0.5 mg / kg). For maintenance of anaesthesia during the 
pre-cardiopulmonary bypass period, a continuous infusion of remifentanil (0.2-0.3 µg / kg / min) 
and sevoflurane (0.8– 1.1% minimum alveolar concentrations) is used. During and post- 
cardiopulmonary bypass, a continuous propofol infusion (3 mg /kg /h) is administered. A 
recruitment maneuver is carried out prior to weaning from cardiopulmonary bypass to prevent 
atelectasis. An external convective warming system with an underbody blanket (Bairhugger®; 
Arizant Healthcare, Eden Prairie, MN) is used after weaning from cardiopulmonary bypass to 
ensure a core temperature of 36°C. After surgery, patients are admitted to the PACU if they are 
in stable hemodynamic condition without (or with minimum) inotropic support and with a core 
temperature of at least 36°C. Only patients scheduled for elective cardiac surgery are admitted 
to the PACU. Postoperative analgesia consists of a bolus of piritramide (0.1 mg/kg) as required 
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and metamizole (1 g every 6 h) to achieve a pain score <4 on visual analogue score from 0 to 10 
(0= no pain, 10= worst pain imaginable). Patients are extubated when they are fully awake, alert, 
hemodynamically stable, recovered full motor power (clinically and TOF>90%), without any 
neurological deficit, core temperature ≥36°C, acceptable blood gases on FiO2 0.4, sufficient tidal 
volume ( 6-8 ml/kg) on minimal ventilator support (P.S. 8cmH2O and PEEP 5cmH2O) and normal 
lactate ,ScvO2, ECG, CXR and without significant bleeding (<100ml/h chest tube drainage). 
Immediately after extubation, all patients undergo a noninvasive ventilation period of 0.5-1h.  
All patients are sent to the intermediate care unit (IMC) if the following criteria are fulfilled: the 
patient must be awake, alert, no neurological deficit, pain score (VAS) <4, hemodynamically 
stable, without or minimal inotropic support with acceptable blood gas analysis (PaO2 >90mmHg 
and PaCO2 <46mmHg, SpO2 >96% on O2 flow 2-6L/min), no significant bleeding (< 50ml / h), 
urinary output >0.5ml/kg/h, normal serum lactate, normal ScvO2, and when cardiac enzymes and 
chest x-ray warrants no further intervention. IMC patients are discharged to the nursing ward 
when they have stable rhythm and are able to mobilize independently. The weaning, extubation 
and transfer criteria are mentioned in table 2. 
 
Table 2: Weaning, extubation and transfer criteria for patients undergoing fast track 
anaesthesia 
 Weaning Criteria: 
 Neuromuscular Monitoring TOF> 90% 
 Decrease the ventilator settings to PSV: PS 10-12 cm H2O, PEEP 8-5 cm H2O, fiO2 
≤40% 
 Acceptable ABG: Pao2 ≥100mmHg, Paco2 ≤45mmHg ( or Horowitz index ≥200 
with a fiO2≤0.4) 
 Normal ventilation mechanics 
 Svo2≥70%, s-Lactate < 4mmol.l-1 without acidosis 





Criteria for Extubation: 
 Full consciousness, no neurologic deficit  
 Hemodynamically stable  
 Core temperature ≥36⁰C 
 Arterial blood gas: Pao2 ≥100 mmHg, Paco2 ≤44 mmHg on FIO2 0.4 
 Normal Svo2 
 Respiratory parameters: sufficient VT (P.S. 8 cm H2O and PEEP 5 cm H2O)  
 Bleeding: <100ml .h-1 
 Normal serum lactate  
 No new ECG and CXR changes  
 
Criteria for Transfer of Patients From PACU to IMC: 
 Fully awake and alert, no neurologic deficit. 
 Hemodynamically stable 
 Without (or minimal) inotropic support 
 Acceptable ABG (Pao2>90 mmHg, Paco2<46 mmHg, Spo2 >96% on o2 insufflation 
2-6 L .min-1)  
 Urinary output >0.5 ml .kg-1 .h-1 
 No significant bleeding (<50 ml .h-1)  
 Normal serum lactate 
 Normal Scvo2  
 Cardiac enzymes and CXR: warrants no further intervention  
 VAS <4 
TOF = Train-of-four, PSV= Pressure support ventilation, P.S. = Pressure support, Scvo2 = Central 
venous oxygen Saturation, CXR=Chest x-ray, ABG= Arterial Blood gas, VAS= Visual analogue score, 







The term “opioid” refers to all drugs, both synthetic and natural, that act on opioid receptors. 
They are the oldest analgesics known in the human history and its use in the practice of 
anaesthesia remains unchallenged[46]. They act through opioid receptors, which belong to the 
family of G protein-coupled receptors. The standard exogenous opioids used in OR are morphine, 
fentanyl, sufentanil, alfentanil and remifentanil (Figure 4).  
 
Figure 4: Chemical structural formulas of clinically used opioids[47]. 
a. Morphine   b. Fentanyl   c. Sufentanil  d. Remifentanil   e. Alfentanil   f. Piritramid   g. Pethidine 
 
4.3.1 Remifentanil: 
Remifentanil is unique ultra-short-acting selective μ-opioid receptor agonist. It is characterized 
by very short context-sensitivity half-life (3-4 minutes) (figure 5), as it is metabolized by unspecific 
blood and tissue esterases and eliminated independently of liver or renal function, and hence has 
predictable pharmacokinetics[48]. At the beginning of remifentanil use, relatively large doses 
were administered (1-5µg/kg/min) with stable intraoperative hemodynamics and early 
extubation and awakening at the end of the procedure. Because of some associated 
complications such as muscle rigidity and bradycardia, smaller doses (0.3 and 0.4 µg/kg/min) were 
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examined in context of cardiac surgery and found to be effective and safe [49]. Patients treated 
with remifentanil may suffer from severe pain immediately postoperatively[50].  
Generally, in comparison with other short acting opioids in general anaesthesia (GA), remifentanil 
was associated with clinical signs of deeper analgesia and anaesthesia, more bradycardia, more 
hypotension, less hypertension, faster recovery, more frequent postoperative analgesic 
requirements, fewer respiratory events requiring naloxone and more postoperative shivering 
with no overall impact on postoperative nausea[50].  
A meta-analysis was done for studies using remifentanil in patients undergoing cardiac surgery. 
It has been suggested that remifentanil may reduce cardiac biomarker release, ventilation time 
and hospital LOS[51]. At the beginning of FTCA era, Myles and Colleagues [52] discussed the 
choice of anaesthetic agents, and they reached a logical conclusion favoring low-dose opioid 
anaesthetic use. 
4.3.2 Sufentanil: 
Sufentanil was first synthetized in 1973. It took about 10 years to be considered as potent opioid 
and can stand in front of routine use of fentanyl at early eighties. The potency of intravenous 
sufentanil is 5-10 times higher than fentanyl. The suggested dose of sufentanil in balanced 
anaesthesia during medium- long surgery is 0.5-1.5µg/kg with supplemental dose of 0.15-
0.7µg/kg and the total procedure dose 2-3µg/kg[53]. 
The continuous infusion doses range from 0.3-1µg/kg/h. The safety of this management is 
determined by its context-sensitive half-time. In comparison with remifentanil, sufentanil has 
longer context sensitive half time (30-35min) after 4-hours supply. After that, sufentanil curve 
increases non-linearly[53](Figure 5). This may have impact on time of eligibility to be transferred 
in lower-dependency unit, and hence the overall costs. 
The pharmacokinetics of sufentanil follows the three compartmental model. Before CPB, the 
linearity of the pharmacokinetics can accurately predict sufentanil concentrations[54]. During 
extracorporeal circulation, marked fluctuation in plasma level was observed due to redistribution 
from the lungs and muscles following a primary decrease in the drug concentration, mostly 
resulting from hemodilution and redistribution to the cardiopulmonary depot. This substantially 
prolongs the half time of elimination. 
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In Vitro, it has found that both remifentanil and sufentanil has cardio-protective effect against re-
oxygenation hypoxia[55]. Moreover, sufentanil preserves hemodynamic parameters as well as 
echocardiographic indices of LV function in patients with ischemic heart disease [56]. This stable 
hemodynamic effects are similar between the patients receiving remifentanil and sufentanil, with 
shorter time to recovery of spontaneous breathing and tracheal extubation in remifentanil 
patients[57]. Contrary to remifentanil, the intraoperative use of sufentanil does not require high 
postoperative analgesia. 
 










5. Objective of the work 
The aim of this retrospective study was to compare the effects of remifentanil and sufentanil on 
a well-established fast-track pathway. The primary end points were ventilation time (i.e. time 
from arrival on the post-anaesthesia care unit until tracheal extubation), length of stay in the 
post-anaesthesia care unit, visual analogue pain scores and piritramide consumption on the day 
of the operation. The secondary end points were length of stay in intermediate care, hospital 
length of stay, fast-track failure, in-hospital mortality and postoperative complications such as 
postoperative nausea and vomiting, delirium and the incidence of tracheal re-intubation. 
 
6. Methods 
This retrospective observational study was performed in a single university-affiliated heart centre, 
was approved by the local research ethics committee and individual patient consent was waived. 
In the period from February to July 2017, we were obliged to change our opioid management 
within our standard fast-track protocol due to the unavailability of remifentanil. During this period 
we decided to use a continuous sufentanil infusion instead. We included all consecutive cardiac 
surgery patients admitted to the post-anaesthesia care unit during this time period. This group 
was compared to an historical group of patients from the same time period the previous year 
(February to July 2016) who had received a continuous remifentanil infusion according to our 
standard fast-track protocol [2].  
For all patients, anaesthesia induction was performed with fentanyl (200 µg) and propofol (1–2 
mg.kg-1). A single dose of rocuronium or atracurium was used for neuromuscular blockade. For 
maintenance of anaesthesia, a continuous infusion of an opioid, in addition to sevoflurane (0.8– 
1.1% MAC) during the pre- cardiopulmonary bypass period were used. During cardiopulmonary 
bypass, and until the end of the operation, a continuous propofol infusion (3 mg.kg -1.h-2) was 
used.  
For patients in the sufentanil group a continuous infusion of sufentanil was used during 
maintenance of anaesthesia; 1 µg.kg-1.h-2 until sternotomy, 0.5 µg.kg-1.h-2 until cardiopulmonary 
20 
 
bypass and 0.25 µg.kg-1.h-2 after weaning from cardiopulmonary bypass and until chest closure 
after which the infusion was stopped. The anaesthetist was allowed to give additional 10-20 µg 
boluses if deemed necessary. Sufentanil group patients were transferred with a propofol infusion 
2 mg.kg-1.h-2 to the post-anaesthesia care unit. For postoperative analgesia, metamizole 1g was 
given before extubation. Boluses of piritramide 0.02-0.03 mg.kg-1 could be given if necessary to 
achieve a target visual analogue pain score of <4. For patients in the remifentanil group an 
uninterrupted continuous infusion of remifentanil (0.2-0.3 µg .kg-1 .min-2) was used throughout 
the operation. During patient transfer from operation room to post-anaesthesia care unit, 
anaesthesia was maintained with remifentanil 0.1-0.15 µg.kg-1.min-2 and propofol 2mg.kg-1.h-2. 
Postoperative analgesia was commenced immediately after arrival in the post-anaesthesia care 
unit as a bolus of piritramide 0.1 mg.kg-1 and intravenous metamizole 1g. Boluses of piritramide 
0.02-0.03 mg.kg-1 could be given if necessary to achieve a target visual analogue pain score of <4.  
At the end of the operation all patients had to fulfill the fast-track criteria. Patients were admitted 
to the post-anaesthesia care unit if they were in a stable haemodynamic condition with a core 
temperature of at least 36°C. Both the surgeon and the anesthetist agreed to a fast-track pathway 
for each patient. The post-anaesthesia care unit operated daily, Monday to Friday from 10:00 h 
to 22:30 h. It was managed by anaesthetists and nursing staff with a nurse to patient ratio of 1:3 
and physician to patient ratio of 1:4.  
Patients’ tracheas were extubated when they fulfilled the extubation criteria (table 2). Patient 
controlled analgesia (PCA) was offered to patients with a high visual analogue pain score and high 
analgesic consumption, either in post-anaesthesia care unit or later in the intermediate care unit, 
according to the attending physician. All patients were monitored for at least 2 h after tracheal 
extubation and were then transferred to the intermediate care unit once they fulfilled the transfer 
criteria (table 2).  
All patients received 4 mg dexamethasone before induction of anaesthesia as postoperative 
nausea and vomiting prophylaxis. Upon arrival at post-anaesthesia care unit, all female patients, 
patients scheduled for thoracotomy or patients with a post-operative nausea and vomiting 
history received 1.25 mg droperidol. Ondansetron 4mg was added in patients with a history of 
postoperative nausea and vomiting. Postoperative delirium was scored before transfer using the 
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nursing delirium screening scale (Nu-DESC), where ≥2 is considered positive. Patients transferred 
from the post-anaesthesia care unit to the intensive care unit (or directly back to the operating 
room), were considered fast-track failure patients. 
For data collection, our clinical information system iMedOne® (Deutsche Telekom Healthcare and 
Security Solutions GmbH, Germany) and our machine-readable patient’s chart Medlinq® (Medlinq 
Softwaresysteme GmbH, Hamburg, Germany) were used. StatsDirect® version 3.0, StatsDirect 
Ltd, Cheshire, UK) for description and analysis. In order to minimise selection bias and to obtain 
comparable groups, a propensity score matching approach was used. For each patient a logistic 
regression model was calculated that included variables known to affect postoperative lengths of 
stay. These included age, sex, co-existing diseases, left ventricular ejection fraction, logistic 
European System for Cardiac Operative Risk Evaluation score (EuroSCORE), type and length of 
surgery, and cardiopulmonary bypass and aortic cross clamp times. Pairs were matched 1:1 with 
their nearest neighbor according to the closest propensity score of each subject. Based on the 
pre-matching range of baseline variable differences, the maximum caliper width for pair-
matching was defined at 0.125 of the pooled logit score standard deviation. Categorical data were 
compared using the χ²-test or Fishers exact test where appropriate. Continuous variables were 
assessed for normal distribution using the Shapiro-Wilks test and data were compared using 
Student’s t-test or Wilcoxon-Mann-Whitney test where appropriate. A p value <0.05 was 
considered statistically significant. 
7. Results 
There were 622 patients in the sufentanil group and 679 patients in the remifentanil group. Eighty 
three patients were excluded during the 1:1 propensity score matching process, resulting in two 







Figure 6: Study flowchart for patients included in the study. 
 
PACU, post-anaesthesia care unit; FT, fast-track; IMC, intermediate care unit; ICU, intensive care unit; OR, 
operating room 
The baseline characteristics and operative data for patients included in the study are shown in 
table 3. 
 
Ventilation time (i.e. time from arrival on post-anaesthesia care unit until tracheal extubation) 
and post-anaesthesia care unit-length of stay were significantly longer in the sufentanil group 
compared with the remifentanil group (Figures 7 and 8). Hospital length of stay was significantly 
longer in the remifentanil group compared with the sufentanil group. There were no differences 







Table 3: Baseline characteristics and operative data for patients included in 










   
 
Age; years 65 (10) 65 (12) 
 
Sex; female 170 (27.9%) 145 (23.8%) 
 




Pre-operative ejection fraction; %  56.1 (10.3) 56.6 (10.5) 0.325 
Pre-operative myocardial 
infarction  
133 (21.8%) 142 (23.3%) 0.548 
Pre-operative diabetes mellitus 197 (32.3%) 187 (30.7%) 0.528 
Pre-operative COPD 32 (5.2%) 36 (5.9%) 0.623 
Pre-operative creatinine level; 
µmol .l-1 
88.1 (36.8) 90.7 (51.7) 0.315 
Pre-operative neurological 
disorder 
68 (11.1%) 72 (11.8%) 0.727 
Urgent Surgery 49 (8.0%) 57 (9.3%) 0.422 
Aortic cross-clamp time; min 53 (36) 54 (37) 0.409 
Cardiopulmonary bypass time; 
min 
73 (48) 75 (49) 0.509 
Operative time; min 193 (57) 190 (62) 0.411 
Type of surgery: 0.923 
 CABG 149 (24.4%) 151 (24.7%) 0.947 
 OPCAB 142 (23.3%) 133 (21.8%) 0.583 
 1x Valve 
replacement/repair 
188 (30.8%) 193 (31.6%) 0.804 
 2x Valve 
replacement/repair 
14 (2.2%) 13 (2.1%) 0.999 
 3x Valve 
replacement/repair 
1 (0.16%) 2 (0.32%) 0.999 
 CABG+1x Valve 
replacement/repair 
58 (9.5%) 60 (9.8%) 0.922 
 CABG+2xValve 
replacement/repair 
1 (0.16%) 2 (0.32%) 0.999 
 CABG+ Others 5 (0.82%) 6 (0.98%) 0.999 
 Valve replacement/repair 
+ Others 
37 (6.0%) 36 (5.9%) 0.999 
 Miscellaneous 14 (2.2%) 13 (2.1%) 0.999 
COPD: chronic obstructive pulmonary disease; CABG:  coronary artery bypass graft; OPCAB: off-




Figure 7. A comparison of the ventilation times between the sufentanil group and the remifentanil 
group. IQR, Interquartile range; UQ, upper quartile; LQ, lower quartile.
 
Figure 8. A comparison of the time to tracheal extubation between the sufentanil group (blue) 




Piritramide requirement during post-anaesthesia care unit stay was significantly higher for patients in the 
remifentanil group compared with those in the sufentanil group. There was no difference in patient controlled 
analgesia requirement between the groups either during their stay in the post-anaesthesia care unit or 
afterwards during their remaining hospital stay. The mean (SD) visual analogue pain score at the end of post-
anaesthesia care unit stay was significantly lower in the sufentanil group compared with the remifentanil 
group (table 4). 
Table 4: Postoperative outcome parameters for patients included in the study.  Values are median (IQR [range]), mean 
(SD) or number (proportion). 
 FT-Sufentanil group FT-Remifentanil 
group 
p value 95% Confidence 
Interval of the 
Difference 
Ventilation time; min  110 (80-150 [15-370])  
 
70(50-100 [5-315]) <0.001 36.3 to 48.3 
PACU-LOS; min 277 (78)  
 
263 (78)  
 
0.002 5.09 to 22.6 
IMC-LOS; h 65.1 (64.0)  
 
68.7 (78.2)  
 
0.364 -11.9 to 4.37 
Hospital length of stay; d 14.1 (6.1)  
 
15.5 (8.8)  
 
0.020 -2.22 to -0.50 
Visual analogue pain score 
(VAS) 
1.5 (1.2)  2.4 (1.5)  <0.001 N/A 
Piritramide requirement; mg 2.6 (4.7)  18.9 (7.3) <0.001 -17.0 to -15.5 
In-PACU PCA requirement  11 (1.8%) 17 (2.7%) 0.339 N/A 
Out-PACU PCA requirement  62 (10.1%) 55 (9.0%) 0.559 N/A 
PACU, post-anaesthesia care unit; IMC, intermediate care unit; LOS, length of stay; PCA, patient 
controlled analgesia 
 
Mean sufentanil consumption was 0.969 µg.kg-1.h-2, with a mean (SD) total consumption of 3.100 
(0.100) µg.kg-1.  There was no correlation between total sufentanil consumption and ventilation 
time (r =0.174). There were no differences between the groups in terms of postoperative 




Table 5: Postoperative complications for patients included in the study. Values are number 
(proportion).  





Fast-track failure 51 (8.3%) 54 (8.8%) 0.760 
Tracheal re-intubation  3 (0.4%) 5 (0.8%) 0.725 
Postoperative nausea and vomiting 95 (15.5%) 92 (15.1%) 0.873 
Postoperative delirium (Nu-DESC≥2) 9 (1.8%)* 8 (2.4%)§ 0.721 
Deaths  1 (0.16%) 4 (0.6%) 0.374 
*n=483      §n=321 
 Nu-DESC, nursing delirium screening scale  
 
8. Discussion  
We have demonstrated that a remifentanil infusion in cardiac surgery patients managed in a 
specialised post-anaesthesia care unit using a fast-track protocol resulted in a significantly shorter 
ventilation time and length of stay in the post-anaesthesia care unit compared with patients who 
received a sufentanil infusion. However, the remifentanil group consumed more analgesics than 
the sufentanil group in order to reach the targeted visual analogue pain score. Remifentanil group 
patients had longer hospital stays, but there was no difference in intermediate care unit length 
of stay. There was no difference in fast-track failure rate, tracheal re-intubation rate, in-hospital 
mortality, postoperative nausea and vomiting, or incidence of early postoperative delirium.  
In contrast to a recently published study [58], we demonstrated a reduction in ventilation time 
and post-anaesthesia care unit length of stay with remifentanil. Bhavsar et al. did not 
demonstrate a difference between the two opioids; the ventilation time in their study was much 
longer, 311 vs 80 min for the remifentanil group and 261 vs 122 min for the sufentanil group. We 
found that the longer the ventilation time, the smaller the difference between groups can be 
noticed (figure 8). The explanation for shorter ventilation times in our study might be differences 
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in our fast-track protocol. Bhavsar et al. attempted to wean patients one hour after their arrival 
in the cardiac recovery unit whereas our weaning protocol started immediately after fulfillment 
of predefined weaning criteria. Another explanation might be the different opening hours of the 
post-anaesthesia care units; in Bhavsar et al.’s study the opening hours were from Monday 
morning to Saturday afternoon whereas our post-anaesthesia care unit was closed overnight. 
Grass et al. [20] showed that limited opening hours led to decreased ventilation time. Differences 
in sufentanil dosages could be another explanation; however we were unable to demonstrate a 
statistically significant correlation between total amount of sufentanil consumed and ventilation 
time. This is in agreement with a study comparing different doses of sufentanil in fast-track 
patients which showed no difference in ventilation time [59]. Different studies have used 
comparable sufentanil dosages to ours but have reported much longer ventilation times. This 
supports our hypothesis that it is not the specific opioid, or the amount of opioid given, but the 
fast-track protocol itself that makes the difference [60, 61]. 
The increased requirement for piritramide in the remifentanil group is in agreement with previous 
studies [50, 58, 60]. This may be explained by the shorter context-sensitive half time of 
remifentanil (3-5 min) compared with sufentanil (30-35 min following a 4 h infusion). Visual 
analogue pain scores were significantly higher in the remifentanil group immediately 
postoperatively but were still within an acceptable range. Lison et al. [60] demonstrated similar 
differences in pain scores during the first hours of weaning, although Gerlach et al. [61] did not 
find any differences in repeated pain score measurements within the first 12 hours 
postoperatively. In our study the need for patient controlled analgesia due to high analgesic 
requirement caused by severe pain was comparable between the two groups, both during and 
after post-anaesthesia care unit stay.  
The sufentanil patients stayed longer in the post-anaesthesia care unit before intermediate care 
unit transfer. Although this was statistically significant it is probably not clinically relevant; 
transfer of patients between different units is subjected to logistical and administrative 
regulations that affect the time of transfer. Other studies have failed to demonstrate a difference 
in length of stay between the two groups [58, 60]. This can be explained by different fast-track 
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pathways between studies (intensive care unit vs. post-anaesthesia care unit) and different 
opening hours. 
Hospital length of stay was longer in the remifentanil group. This may be due to health system 
policy variance during the different time periods or due to less availability of step-down 
rehabilitation facilities during certain time periods. The use of remifentanil and the resultant 
postoperative pain might also possibly be the cause of this difference in hospital length of stay 
and could not be excluded. However, a Cochrane review on fast-track cardiac anaesthesia [1], 
indicated no difference in hospital length of stay, even in patients treated with high dose opioids 
without a time-directed tracheal extubation protocol.  
In our study fast-track failure was defined as any unplanned transfer of the fast-track patient from 
post-anaesthesia care unit directly to the intensive care unit or a return to the operating theatre. 
There was a comparable low fast-track failure rate of 8% in both groups. This is in agreement with 
Lison et al. [60] who excluded approximately 10% in each of their groups due to failure in 
completion of the fast-track pathway. In contrast to Lison et al. [60], we did not find a high 
incidence of postoperative nausea and vomiting in our remifentanil group. This may be due to 
our post-operative nausea and vomiting prophylaxis strategy and a remifentanil systematic 
review supports our results [50]. We did not find any differences between our groups in the 
incidence of postoperative delirium, assessed before transfer from the post-anaesthesia care 
unit, suggesting that the type of opioid per se is not a risk factor for development of postoperative 
delirium. This is in accordance with the findings of a prospective randomised study comparing the 
incidence of postoperative cognitive dysfunction (POCD) in cardiac surgical patients [62]. A 
ventilation time of more than 300 minutes, rather than the choice of opioid, was associated with 
POCD. This is in agreement with a recent study investigating causes of post-cardiac surgery 
delirium [63].  
The main limitation of our study is its retrospective design resulting in a risk of potential bias. This 
is especially true for the significant difference in length of hospital stay between the two groups 
and may be the result of ‘immortal time bias’ i.e. the concept that overall improvements in patient 
care occur more recently. An advantage of this study is the large number of patients included; it 




In conclusion, although ventilation time and post-anaesthesia care unit length of stay were 
shorter in the remifentanil group, sufentanil may be superior to remifentanil because it provided 
improved analgesia and resulted in a shorter hospital length of stay. However, we believe that a 
detailed and time-directed weaning protocol is more important than the use of a specific opioid 
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The main drives of development of fast track cardiac anaesthesia are the increase burden of 
health care cost and the shortage of intensive care beds. Fast track (FT) is multidisciplinary process 
that leads to rapid patient recovery and discharge without affecting morbidity and mortality. Fast 
track cardiac anaesthesia (FTCA) was proved to be safe, efficient and economically effective.  
Leipzig FT protocol was first introduced in November 2005 for elective cardiac surgery patients in 
the heart center of Leipzig University. It is characterized by using intraoperative remifentanil as 
main opioid with treating the patients postoperatively in post-anaesthesia care unit (PACU) 
completely bypassing ICU admission.  
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Remifentanil was unavailable in Germany from February to July 2017, therefore the protocol had 
to be modified and sufentanil was used instead. The aim of this retrospective study was to 
compare the effects of remifentanil and sufentanil on the well-established FT concept. The 
primary end points were ventilation time, LOS in PACU (LOS PACU), the visual analogue score 
(VAS) and the piritramide consumption on the day of operation. The secondary end points were 
LOS in intermediate care (LOS IMC), hospital LOS, FT failure (FTF), in-hospital mortality and 
postoperative complications such as postoperative nausea and vomiting (PONV), delirium and the 
incidence of reintubation. 
All cardiac surgery patients consecutively admitted to PACU during the period from February to 
July 2017 (n=622), received sufentanil (FT-S), were compared to patients (n=679) from the same 
time period of the previous year treated with continuous remifentanil infusion (FT-R) according 
to the standard FT protocol. To minimise selection bias and to obtain comparable groups, we used 
a 1:1 nearest neighbour propensity score matching approach resulted in total 1218 patients 
divided in 2 equal groups. 
In FT-R, an uninterrupted continuous infusion of remifentanil (0.2-0.3 µg/kg/min) was used for 
maintenance of anaesthesia throughout the whole operation. In FT-S, a continuous infusion of 
sufentanil was used during maintenance of anaesthesia as follows: 1 µg/kg/h until sternotomy, 
0.5 µg/kg/h until cardiopulmonary bypass and 0.25 µg/kg/h until chest closure, then the infusion 
was stopped. Otherwise, the Leipzig FT protocol was used as previously published. 
Remifentanil was more effective in reducing time to extubation (by 40 minutes) and length of stay 
in the post anaesthetic care unit during fast track cardiac anaesthesia than sufentanil. There was 
an increased need of piritramide when remifentanil was used. The hospital length of stay was 
longer in remifentanil group. There were no differences between both groups regarding 
postoperative complications. Clinically, a detailed and time-directed weaning protocol is more 
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